(Q33804467)

29 July 2017

1 reference

title

Immunosuppressant-induced nephropathy: pathophysiology, incidence and management (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

A J Olyaei

1

1 reference

29 July 2017

A M de Mattos

series ordinal

2

1 reference

29 July 2017

W M Bennett

series ordinal

3

1 reference

29 July 2017

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

21

1 reference

29 July 2017

6

1 reference

29 July 2017

471-488

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199921060-00004

29 July 2017

0 references

cites work

Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection

1 reference

12 December 2020

Mechanisms of action and overview of OKT3.

1 reference

12 December 2020

Hemolytic uremic syndrome in renal allografted patients treated with cyclosporin.

1 reference

12 December 2020

The UNOS Scientific Renal Transplant Registry--1991

1 reference

12 December 2020

Therapy with cyclosporine in psoriatic arthritis

1 reference

12 December 2020

Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy

1 reference

12 December 2020

Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation

1 reference

12 December 2020

Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation.

1 reference

12 December 2020

Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine

1 reference

12 December 2020

Comparative evaluations of neuroperformance and clinical outcome assessments in chronic progressive multiple sclerosis: I. Reliability, validity and sensitivity to disease progression. Multiple Sclerosis Study Group

1 reference

12 December 2020

Therapeutic monitoring of tacrolimus

1 reference

12 December 2020

Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study

1 reference

12 December 2020

Antilymphocyte antibodies in the treatment of allograft rejection: targets, mechanisms of action, monitoring, and efficacy

1 reference

12 December 2020

Possible nephrotoxicity of the prophylactic use of OKT3 monoclonal antibody after cadaveric renal transplantation

1 reference

12 December 2020

Efficacy and safety of low molecular weight heparin in renal transplantation.

1 reference

12 December 2020

Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats

1 reference

12 December 2020

The effects of oral pentoxifylline on the cytokine release syndrome during inductive OKT3

1 reference

12 December 2020

Time course of the decline in renal function in cyclosporine-treated heart transplant recipients

1 reference

12 December 2020

Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition

1 reference

12 December 2020

Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period

1 reference

12 December 2020

Prevention of acute cyclosporine nephrotoxicity in rabbits with a prostacyclin analogue

1 reference

12 December 2020

Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake

1 reference

12 December 2020

Cyclosporine-induced renal dysfunction in experimental animals and humans.

1 reference

12 December 2020

Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects

1 reference

12 December 2020

Renal side-effects of cyclosporin A with special reference to autoimmune diseases

1 reference

12 December 2020

Studies of cyclosporine-associated arteriolopathy in renal transplantation: does the long-term outcome of renal allografts depend on chronic cyclosporine nephrotoxicity?

1 reference

12 December 2020

Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies.

1 reference

12 December 2020

General aspects of cytokine-release syndrome: timing and incidence of symptoms.

1 reference

12 December 2020

The role of OKT3 in clinical transplantation

1 reference

12 December 2020

Effect of cilastatin on cyclosporine-induced acute nephrotoxicity in kidney transplant recipients

1 reference

12 December 2020

Functional and structural characteristics of experimental FK 506 nephrotoxicity

1 reference

12 December 2020

Cyclosporine-associated chronic nephropathy

1 reference

12 December 2020

Tacrolimus: a new immunosuppressive agent.

1 reference

12 December 2020

Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation

1 reference

12 December 2020

Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

1 reference

12 December 2020

Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A

1 reference

12 December 2020

Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands

1 reference

12 December 2020

Elective cyclosporine withdrawal 1 year after renal transplantation

1 reference

12 December 2020

Is cyclosporine indicated in HLA-identical renal transplant recipients?

1 reference

12 December 2020

Ciclosporin-associated arteriolopathy: the renin producing vascular smooth muscle cells are more sensitive to ciclosporin toxicity

1 reference

12 December 2020

Cyclosporine improves results in HLA-identical sibling renal transplants

1 reference

12 December 2020

Calcineurin and the biological effect of cyclosporine and tacrolimus

1 reference

12 December 2020

Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group

1 reference

12 December 2020

FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818

1 reference

12 December 2020

Placebo-controlled study of a humanized anti-TAC monoclonal antibody in dual therapy for prevention of acute rejection after renal transplantation.

1 reference

12 December 2020

Prevention of cyclosporine-induced nephrotoxicity with transdermal clonidine

1 reference

12 December 2020

Nephrotoxicity of immunosuppressive drugs.

1 reference

12 December 2020

Chronic cyclosporine nephrotoxicity

1 reference

12 December 2020

Neoral: the new cyclosporine

1 reference

12 December 2020

Prevention of cyclosporine-induced nephrotoxicity with dietary glycine

1 reference

12 December 2020

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

1 reference

12 December 2020

The differential diagnosis between rejection and cyclosporine toxicity.

1 reference

12 December 2020

Dietary supplementation with LSL 90202, a lisine salt of eicosapentaenoic acid, in prevention of cyclosporine nephrotoxicity

1 reference

12 December 2020

Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group

1 reference

12 December 2020

Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats

1 reference

12 December 2020

Mismatched family bone marrow transplantation

1 reference

12 December 2020

Immunosuppressants: cellular and molecular mechanisms of action

1 reference

12 December 2020

Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients

1 reference

12 December 2020

Experimental chronic renal ischemia: morphologic and immunologic studies

1 reference

12 December 2020

Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy.

1 reference

12 December 2020

Randomized prospective trial of elective cyclosporine withdrawal from triple therapy at 6 months after cadaveric renal transplantation

1 reference

12 December 2020

Rescue therapy with tacrolimus (FK 506) in renal transplant recipients--a Scandinavian multicenter analysis

1 reference

12 December 2020

Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants

1 reference

12 December 2020

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

1 reference

12 December 2020

The use of therapeutic drug monitoring to optimise immunosuppressive therapy

1 reference

12 December 2020

Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances

1 reference

12 December 2020

Cyclosporine-induced sympathetic activation and hypertension after heart transplantation

1 reference

12 December 2020

The clinical role of OKT3.

1 reference

12 December 2020

Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients

1 reference

12 December 2020

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

1 reference

12 December 2020

Mechanisms of acute and chronic nephrotoxicity from immunosuppressive drugs

1 reference

12 December 2020

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

1 reference

12 December 2020

CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION

1 reference

12 December 2020

Clinical pharmacokinetics of tacrolimus

1 reference

12 December 2020

Cytokine-release syndrome: differences between high and low doses of OKT3

1 reference

12 December 2020

Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection

1 reference

12 December 2020

Cyclosporine nephrotoxicity: implications for dermatology

1 reference

12 December 2020

Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation

1 reference

12 December 2020

Induction of thromboses within renal grafts by high-dose prophylactic OKT3

1 reference

12 December 2020

Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation

1 reference

12 December 2020

Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles

1 reference

12 December 2020

Living-donor renal transplantation in SEOPF. The impact of histocompatibility, transfusions, and cyclosporine on outcome

1 reference

12 December 2020

Cyclosporin-A therapy in severe uveitis of Behçet's disease.

1 reference

12 December 2020

Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation

1 reference

12 December 2020

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

12 December 2020

Renal injury induced by long-term administration of cyclosporin A to rats

1 reference

12 December 2020

Prolonged remission induced by cyclosporine in a patient with familial thrombocytopenia and enteropathy

1 reference

12 December 2020

Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells

1 reference

12 December 2020

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

1 reference

12 December 2020

A new immunosuppressant: tacrolimus

1 reference

12 December 2020

Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome

1 reference

12 December 2020

Vasomotor responses in cyclosporin A-treated rats after chronic angiotensin blockade

1 reference

12 December 2020

Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in patients with renal allografts

1 reference

12 December 2020

Do we know the site of action of cyclosporin?

1 reference

12 December 2020

Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations.

1 reference

12 December 2020

Optimizing the use of cyclosporine in renal transplantation

1 reference

12 December 2020

A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric renal transplantation

1 reference

12 December 2020

Monitoring OKT3 treatment: pharmacodynamic and pharmacokinetic measures

1 reference

12 December 2020

Renal structure and function effects after low dose cyclosporine in psoriasis patients: a preliminary report

1 reference

12 December 2020

Mycophenolate mofetil, tacrolimus, Neoral: from clinical trials to the clinic

1 reference

12 December 2020

OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival

1 reference

12 December 2020

Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity

1 reference

12 December 2020

Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy

1 reference

12 December 2020

Cyclosporine consensus conference: with emphasis on the treatment of psoriasis

1 reference

12 December 2020

Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up

1 reference

12 December 2020

Azathioprine vs cyclosporine in recipients of HLA-identical renal allografts.

1 reference

12 December 2020

A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation

1 reference

12 December 2020

Evolution of renal function during treatment of kidney graft rejection with OKT3 monoclonal antibody

1 reference

12 December 2020

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

12 December 2020

Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients

1 reference

12 December 2020

Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression

1 reference

12 December 2020

Indications for tacrolimus anti-rejection therapy in liver allograft recipients.

1 reference

12 December 2020

Early recurrence of hemolytic uremic syndrome in a renal transplant recipient during prophylactic OKT3 therapy

1 reference

12 December 2020

Does cyclosporine improve the results of HLA-identical renal transplantation?

1 reference

12 December 2020

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

12 December 2020

OKT3-induced cytokine release attenuation by high-dose methylprednisolone

1 reference

12 December 2020

Efficacy of verapamil in prevention of cyclosporine nephrotoxicity in the rat

1 reference

12 December 2020

Vascular mechanisms of cyclosporin-induced hypertension in the rat

1 reference

12 December 2020

Comparison between glomerular filtration rate and renal plasma flow between kidney and heart transplant recipients maintained on a similar cyclosporine dosage

1 reference

12 December 2020

Bioavailability and pharmacokinetics of cyclosporine formulations: Neoral vs Sandimmune

1 reference

12 December 2020

Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy

1 reference

12 December 2020

Cytokine nephropathy during antilymphocyte therapy

1 reference

12 December 2020

Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients

1 reference

12 December 2020

Long-term effects of cyclosporine on renal function in liver transplant recipients.

1 reference

12 December 2020

Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection

1 reference

12 December 2020

Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril

1 reference

12 December 2020

Switching between cyclosporin formulations. What are the risks?

1 reference

12 December 2020

The long-term effects of prophylactic OKT3 monoclonal antibody in cadaver kidney transplantation--a single-center, prospective, randomized study

1 reference

12 December 2020

Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats

1 reference

12 December 2020

Procoagulant effect of the OKT3 monoclonal antibody: involvement of tumor necrosis factor

1 reference

12 December 2020

OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies

1 reference

12 December 2020

The evolution and future of immunosuppression in renal transplantation

1 reference

12 December 2020

Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex

1 reference

12 December 2020

Prevention of cyclosporine-induced nephrotoxicity by prazosin hydrochloride, an alpha-1-adrenoreceptor blocker

1 reference

12 December 2020

Effects of renal impairment on liver transplantation

1 reference

12 December 2020

Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report

1 reference

12 December 2020

The kidney in liver transplantation

1 reference

12 December 2020

Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity

1 reference

12 December 2020

Pharmacology of immunosuppressive medications used in renal diseases and transplantation

1 reference

12 December 2020

Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review

1 reference

12 December 2020

Cyclosporine-induced nephrotoxicity: pathophysiology of decreased blood flow

1 reference

12 December 2020

Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide

1 reference

12 December 2020

Insights into chronic cyclosporine nephrotoxicity.

1 reference

12 December 2020

Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation

1 reference

12 December 2020

Therapeutic monitoring of tacrolimus (FK 506)

1 reference

12 December 2020

A brief review of histopathology in kidney transplant recipients immunosuppressed with cyclosporin A.

1 reference

12 December 2020

Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis

1 reference

12 December 2020

Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury

1 reference

12 December 2020

Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients

1 reference

12 December 2020

The mechanism of action of FK-506 and cyclosporin A.

1 reference

12 December 2020

FK506 nephrotoxicity: morphologic and physiologic characterization of a rat model

1 reference

12 December 2020

Long-term efficacy and safety of cyclosporine in renal-transplant recipients

1 reference

12 December 2020

Prevention of cyclosporine-induced nephrotoxicity by clenbuterol, a beta 2-adrenoreceptor stimulant

1 reference

12 December 2020

Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3.

1 reference

12 December 2020

Cyclosporine: immunology, pharmacology and therapeutic uses

1 reference

12 December 2020

Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups

1 reference

12 December 2020

Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis

1 reference

12 December 2020

The effect of cyclosporine on early graft function in human renal transplantation

1 reference

12 December 2020

10.2165/00002018-199921060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference